McKesson Corp. will acquire US Oncology, which offers a network of 1,300 affiliated physicians offering evidence-based treatment and access to clinical trials, as well as software applications, hematology services and a drug distribution center, for $2.16 billion. The transaction includes the assumption of US Oncology's outstanding debt.

Based in The Woodlands, Texas, US Oncology sells the iKnowMed oncology electronic health records system, as well as a Web portal to enable physician collaboration. The EHR tracks the use of treatment pathways and their effectiveness, and includes analytics to identify appropriate patients for specific clinical trials.

McKesson will continue with the planned beta testing for Lynx EMR, its own oncology electronic records system, during the fall of 2010, and US Oncology will continue to support the iKnowMed EHR, according to a statement from McKesson. "The long-term strategy for McKesson's EMR offering will be determined during the integration planning process, and we believe that the combined expertise of the two organizations will allow us to provide community oncologists with the next generation of leading technology solutions."

The vendors expect the acquisition to close by December 31. McKesson anticipates the acquisition, excluding transaction and integration costs, will be neutral to earnings during the current 2011 fiscal year and modestly add to earnings in FY 2012.

Bruce Broussard, chair and CEO at US Oncology, will lead the McKesson Specialty Care Solutions business unit. More information is available at and

--Joseph Goedert


Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access